These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 23026812)
41. Escitalopram and NHT normalized stress-induced anhedonia and molecular neuroadaptations in a mouse model of depression. Burstein O; Franko M; Gale E; Handelsman A; Barak S; Motsan S; Shamir A; Toledano R; Simhon O; Hirshler Y; Chen G; Doron R PLoS One; 2017; 12(11):e0188043. PubMed ID: 29141007 [TBL] [Abstract][Full Text] [Related]
42. Adult hippocampal neurogenesis: an actor in the antidepressant-like action. Mendez-David I; Hen R; Gardier AM; David DJ Ann Pharm Fr; 2013 May; 71(3):143-9. PubMed ID: 23622692 [TBL] [Abstract][Full Text] [Related]
43. Genetic differences in cytochrome P450 enzymes and antidepressant treatment response. Hodgson K; Tansey K; Dernovsek MZ; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Smith R; Craig IW; Farmer AE; Aitchison KJ; Belsey S; Davis OS; Uher R; McGuffin P J Psychopharmacol; 2014 Feb; 28(2):133-41. PubMed ID: 24257813 [TBL] [Abstract][Full Text] [Related]
44. Housing conditions modulate escitalopram effects on antidepressive-like behaviour and brain neurochemistry. Bjørnebekk A; Mathé AA; Gruber SH; Brené S Int J Neuropsychopharmacol; 2008 Dec; 11(8):1135-47. PubMed ID: 18570703 [TBL] [Abstract][Full Text] [Related]
45. The genome-wide expression effects of escitalopram and its relationship to neurogenesis, hippocampal volume, and antidepressant response. Powell TR; Murphy T; de Jong S; Lee SH; Tansey KE; Hodgson K; Uher R; Price J; Thuret S; Breen G Am J Med Genet B Neuropsychiatr Genet; 2017 Jun; 174(4):427-434. PubMed ID: 28394502 [TBL] [Abstract][Full Text] [Related]
46. Antidepressant effects of nortriptyline and escitalopram in the GENDEP study: is one better than the other? Uher R; Mors O; McGuffin P Acta Psychiatr Scand; 2013 Apr; 127(4):330. PubMed ID: 23480387 [No Abstract] [Full Text] [Related]
48. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Uher R; Perroud N; Ng MY; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Zagar T; Czerski PM; Jerman B; Larsen ER; Schulze TG; Zobel A; Cohen-Woods S; Pirlo K; Butler AW; Muglia P; Barnes MR; Lathrop M; Farmer A; Breen G; Aitchison KJ; Craig I; Lewis CM; McGuffin P Am J Psychiatry; 2010 May; 167(5):555-64. PubMed ID: 20360315 [TBL] [Abstract][Full Text] [Related]
49. Comparison of the effects of escitalopram and nortriptyline on painful symptoms in patients with major depression. Jaracz J; Gattner K; Moczko J; Hauser J Gen Hosp Psychiatry; 2015; 37(1):36-9. PubMed ID: 25480462 [TBL] [Abstract][Full Text] [Related]
50. Escitalopram versus nortriptyline: how to let the clinical GENDEP data tell us what they contained. Bech P; Allerup P; Larsen ER; Csillag C; Licht RW Acta Psychiatr Scand; 2013 Apr; 127(4):328-9. PubMed ID: 23480386 [No Abstract] [Full Text] [Related]
51. Synergy of oxytocin and citalopram in modulating Itgb3/Chl1 interplay: Relevance to sensitivity to SSRI therapy. Stanić D; Oved K; Israel-Elgali I; Jukić M; Batinić B; Puškaš N; Shomron N; Gurwitz D; Pešić V Psychoneuroendocrinology; 2021 Jul; 129():105234. PubMed ID: 33930757 [TBL] [Abstract][Full Text] [Related]
52. Dose-dependent opposite effects of nortriptyline on affective-like behavior in adolescent rats: Comparison with adult rats. Bis-Humbert C; García-Cabrerizo R; García-Fuster MJ Eur J Pharmacol; 2021 Nov; 910():174465. PubMed ID: 34464602 [TBL] [Abstract][Full Text] [Related]
53. A shift toward T helper 2 responses and an increase in modulators of innate immunity in depressed patients treated with escitalopram. Ho PS; Yeh YW; Huang SY; Liang CS Psychoneuroendocrinology; 2015 Mar; 53():246-55. PubMed ID: 25647343 [TBL] [Abstract][Full Text] [Related]
54. The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs. Quesseveur G; Gardier AM; Guiard BP Curr Drug Targets; 2013 Oct; 14(11):1277-94. PubMed ID: 24020973 [TBL] [Abstract][Full Text] [Related]
55. Neurogenesis as a new target for the development of antidepressant drugs. Pascual-Brazo J; Baekelandt V; Encinas JM Curr Pharm Des; 2014; 20(23):3763-75. PubMed ID: 24180394 [TBL] [Abstract][Full Text] [Related]
56. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. Uher R; Maier W; Hauser J; Marusic A; Schmael C; Mors O; Henigsberg N; Souery D; Placentino A; Rietschel M; Zobel A; Dmitrzak-Weglarz M; Petrovic A; Jorgensen L; Kalember P; Giovannini C; Barreto M; Elkin A; Landau S; Farmer A; Aitchison KJ; McGuffin P Br J Psychiatry; 2009 Mar; 194(3):252-9. PubMed ID: 19252156 [TBL] [Abstract][Full Text] [Related]
57. Behavioural and transcriptional effects of escitalopram in the chronic escape deficit model of depression. Benatti C; Alboni S; Blom JM; Gandolfi F; Mendlewicz J; Brunello N; Tascedda F Behav Brain Res; 2014 Oct; 272():121-30. PubMed ID: 24978096 [TBL] [Abstract][Full Text] [Related]
58. Vitamins C and D Exhibit Similar Antidepressant Effects to Escitalopram Mediated by NOx and FKBPL in a Stress-Induced Mice Model. Gammoh O; Ibrahim A; Qnais E; Alqudah A; Altaber S; Aljabali AAA; Tambuwala MM Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375593 [TBL] [Abstract][Full Text] [Related]
59. DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP. Powell TR; Smith RG; Hackinger S; Schalkwyk LC; Uher R; McGuffin P; Mill J; Tansey KE Transl Psychiatry; 2013 Sep; 3(9):e300. PubMed ID: 24002086 [TBL] [Abstract][Full Text] [Related]
60. Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients. Cattaneo A; Ferrari C; Uher R; Bocchio-Chiavetto L; Riva MA; ; Pariante CM Int J Neuropsychopharmacol; 2016 Oct; 19(10):. PubMed ID: 27207917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]